MarketCap
Facebook
X
TelegramLianluo Smart Limited ROCE Ratio 2011-2026 | LLIT
Annual ROCE Ratio Lianluo Smart Limited
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| -89.32 | 422.88 | -218.11 | -39.26 | -65.92 | -92.43 | -8.36 | 1.56 | 12.75 | 11.9 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 422.88 | -218.11 | -6.43 |
ROCE Ratio of other stocks in the Medical devices industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
-182.32 | $ 2.23 | 0.52 % | $ 3.48 M |  USA |
 |
Acutus Medical
AFIB
|
1334.24 | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
-24.19 | - | 3.58 % | $ 2.21 M | USA |
 |
AdaptHealth Corp.
AHCO
|
5.98 | $ 10.41 | -0.41 % | $ 1.41 B | USA |
 |
ClearPoint Neuro
CLPT
|
-86.24 | $ 9.43 | -15.49 % | $ 267 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-6.16 | - | - | $ 1.77 B | USA |
 |
Alphatec Holdings
ATEC
|
-660.94 | $ 13.01 | -0.34 % | $ 1.95 B | USA |
 |
Cytosorbents Corporation
CTSO
|
-151.13 | $ 0.66 | -3.69 % | $ 35.9 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-191.02 | - | -5.86 % | $ 30.6 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-3.22 | $ 4.05 | 0.02 % | $ 151 M |  France |
 |
Avinger
AVGR
|
268.22 | - | -20.74 % | $ 369 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
6.76 | $ 8.28 | -0.96 % | $ 594 M |  Israel |
 |
Establishment Labs Holdings
ESTA
|
-165.66 | $ 64.65 | -0.55 % | $ 1.91 B |  Costa-rica |
 |
Aziyo Biologics
AZYO
|
-97.25 | - | 1.37 % | $ 20.5 M | USA |
 |
Butterfly Network
BFLY
|
-44.07 | $ 4.16 | -2.58 % | $ 881 M | USA |
 |
BIOLASE
BIOL
|
7261.94 | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
-85.42 | - | - | $ 16.4 M | USA |
 |
Boston Scientific Corporation
BSX
|
14.91 | $ 70.72 | -0.67 % | $ 105 B | USA |
 |
Apollo Endosurgery
APEN
|
-96.4 | - | - | $ 475 M | USA |
 |
CONMED Corporation
CNMD
|
9.93 | $ 37.25 | -0.24 % | $ 1.16 B | USA |
 |
CryoLife, Inc.
CRY
|
0.33 | - | -4.14 % | $ 702 M | USA |
 |
Cutera
CUTR
|
-60.43 | - | -10.19 % | $ 1.99 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-804.35 | - | 1.15 % | $ 34.5 M | USA |
 |
InMode Ltd.
INMD
|
12.27 | $ 13.55 | -0.73 % | $ 876 M | Israel |
 |
Dynatronics Corporation
DYNT
|
-75.2 | - | 14.99 % | $ 929 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-11.39 | - | - | $ 3.31 B | USA |
 |
IRIDEX Corporation
IRIX
|
-105.09 | $ 1.33 | - | $ 21.5 M | USA |
 |
Soliton, Inc.
SOLY
|
-46.49 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-124.26 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-22.41 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
-10.4 | - | - | $ 462 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-8.49 | $ 16.91 | -1.77 % | $ 397 M | USA |
 |
Neovasc
NVCN
|
-344.26 | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
2.84 | $ 18.43 | -0.11 % | $ 121 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-36.94 | - | - | $ 955 M | USA |
 |
GBS
GBS
|
-355.28 | - | -0.57 % | $ 7.12 M | USA |
 |
Abbott Laboratories
ABT
|
15.45 | $ 109.71 | -0.9 % | $ 191 B | USA |
 |
Delcath Systems
DCTH
|
0.59 | $ 9.59 | -1.54 % | $ 344 M | USA |
 |
Bio-Rad Laboratories
BIO
|
4.09 | $ 268.09 | -0.52 % | $ 7.56 B | USA |
 |
Helius Medical Technologies
HSDT
|
-528.85 | $ 2.1 | -3.46 % | $ 1.28 M | USA |
 |
AxoGen
AXGN
|
-6.09 | $ 32.26 | -1.51 % | $ 1.49 B | USA |
 |
Align Technology
ALGN
|
15.77 | $ 172.39 | -2.12 % | $ 12.9 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
1.84 | $ 8.78 | -3.52 % | $ 676 M | USA |
 |
Bruker Corporation
BRKR
|
14.21 | $ 33.42 | -0.95 % | $ 4.98 K | USA |
 |
BioSig Technologies
BSGM
|
978.11 | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
-44.33 | $ 3.9 | 4.28 % | $ 160 M | USA |
 |
Second Sight Medical Products
EYES
|
-140.13 | - | -0.97 % | $ 54.4 M | USA |
 |
Accuray Incorporated
ARAY
|
9.66 | $ 0.37 | -4.45 % | $ 38 M | USA |
 |
IRadimed Corporation
IRMD
|
27.63 | $ 103.06 | 0.25 % | $ 1.31 B | USA |